have marketed pens loaded with specific oil formulas designed to inspire feelings of calm, relief, or passion. But now, companies are taking the mood formula mindset one step further, using lab testing and app-driven databases to give consumers an accurate look at the composition of what they’re ingesting — and how each specific chemical compound will make them feel.
Like Gofire, other startups are using technology to standardize a session. Because federal restrictions still heavily inhibit cannabis research, tech companies are hoping their devices will help consumers adequately track and monitor their own doses — creating personal cannabis data in the process. Ionic’s vapes — which they hope to release by the end of the year — can be personalized via the app, tailored to consumers’ specific needs. For instance, a user can limit their intake to 20 hits a day, or program it to only allow a 10-second draw. Users can also input the cannabinoid ratios of the oil they’re loading into the device and the app’s algorithm purports to predict how a specific dose will impact you, based on their height, weight, and BMI.
Over the course of four years, researchers not only performed clinical trials on the inhaler, but worked to designate a standard dose. The sweet spot, Davidson says, is between .25 milligrams and .5 milligrams of THC per one inhalation. “That’s the dose patients find that therapeutic window between relief and psychoactivity,” Davidson says. Their device wasby the Israeli Ministry of Health for physician prescription; doctors can even remotely change the dosage on a patient’s inhaler.
So many idiots
unbelievable fancy letting the people decide.😉
Go ahead apply for the weed lose your right to own firearms. We need them with idiots an false sayers like rolling stones
Ridiculous
BLC_Strawn
No strain, no gain. :)
How do you get a consistent high? That's an easy one man. One just has to be very consistent at consistently smoking the good old herb of joy! 😝
Some of us are just ignorant...and blow matches anyhow😂
Such dilemmas.